Table S2. Baseline Characteristics and Comorbid Conditions in Stage 3â5 NDD-CKD Patients, 20% Medicare and Commercially Insured (MarketScan) Datasets. (PDF 105 kb
Table S1. One-way ANOVA comparing the various Biochemical parameters in patients stratified for ESRD...
Appendix Table S2. Characteristics of primary care patients with CKD based on eGFR (n =â1767). Pa...
Methods. Details on the Davies comorbidity score, KDQOL-SFâ˘, and treatment burden outcomes. (PDF 1...
Table S4. Anemia Treatment in Stage 3â5 NDD-CKD Patients with Anemia by Stage, 20% Medicare and Co...
Table S1. Codes Used to Identify CKD, Anemia, Treatment, and Comorbid Conditions. (PDF 35 kb
Figure S1. Flowchart for patient selection. CKD, chronic kidney disease; ESRD, end-stage renal disea...
Appendix Table S3. Patients with Documented Nephrology Consultations (n =â389). Logistic regressi...
Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...
Table S3. Association of different cutoff values of ferritin and TSAT, adjusted for age and sex, wit...
Table S1. Definitions for Comorbid Health Conditions. Provides the diagnostic codes used to define t...
Table S1. Comparing characteristics of the Included versus Excluded Participants. Table S2. Baseline...
Figure S2. Kaplan-Meier survival curves comparing patients âĽ70 years choosing dialysis or conserv...
Excluded cases. Details of excluded cases including table of demographic and outcome data. (DOCX 24 ...
Table S2. Use of medication at least once during the study period. This table provides information a...
Item 1: Search strategies. Item 2: Quality appraisal of included studies. Item 3: Supplementary tabl...
Table S1. One-way ANOVA comparing the various Biochemical parameters in patients stratified for ESRD...
Appendix Table S2. Characteristics of primary care patients with CKD based on eGFR (n =â1767). Pa...
Methods. Details on the Davies comorbidity score, KDQOL-SFâ˘, and treatment burden outcomes. (PDF 1...
Table S4. Anemia Treatment in Stage 3â5 NDD-CKD Patients with Anemia by Stage, 20% Medicare and Co...
Table S1. Codes Used to Identify CKD, Anemia, Treatment, and Comorbid Conditions. (PDF 35 kb
Figure S1. Flowchart for patient selection. CKD, chronic kidney disease; ESRD, end-stage renal disea...
Appendix Table S3. Patients with Documented Nephrology Consultations (n =â389). Logistic regressi...
Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...
Table S3. Association of different cutoff values of ferritin and TSAT, adjusted for age and sex, wit...
Table S1. Definitions for Comorbid Health Conditions. Provides the diagnostic codes used to define t...
Table S1. Comparing characteristics of the Included versus Excluded Participants. Table S2. Baseline...
Figure S2. Kaplan-Meier survival curves comparing patients âĽ70 years choosing dialysis or conserv...
Excluded cases. Details of excluded cases including table of demographic and outcome data. (DOCX 24 ...
Table S2. Use of medication at least once during the study period. This table provides information a...
Item 1: Search strategies. Item 2: Quality appraisal of included studies. Item 3: Supplementary tabl...
Table S1. One-way ANOVA comparing the various Biochemical parameters in patients stratified for ESRD...
Appendix Table S2. Characteristics of primary care patients with CKD based on eGFR (n =â1767). Pa...
Methods. Details on the Davies comorbidity score, KDQOL-SFâ˘, and treatment burden outcomes. (PDF 1...